Medical education company Pri-Med said on Tuesday that it has entered into a new partnership with the Brain Aneurysm Foundation (BAF) to deliver "Update in Diagnosis and Management of Intracranial Aneurysms for Primary Health Care Providers" at Pri-Med Midwest in Rosemont, IL on 10 October 2018.
During the medical session, Sepideh Amin-Hanjani, MD, University of Illinois at Chicago, will address how to recognise signs of an aneurysm rupture, when to make a referral and order appropriate imaging, and best practices for educating the patient about the risk factors for aneurysm formation and rupture.
According to the company, one in 50 people in the US has an unruptured brain aneurysm and 30,000 of them rupture every year. Despite low frequency, brain aneurysms are high in mortality, because the lack of a timely diagnosis often leads to death.
This session will focus on the importance of proper diagnosis and scanning and faculty will discuss treatment options to use in practice to meet the need for early detection of brain aneurysm.
Brain Aneurysm Foundation (BAF) is a non-profit organization dedicated to providing critical awareness, education, support, advocacy, and research funding to reduce the incidence of brain aneurysm ruptures.
Cartography Biosciences partners with Pfizer to discover tumour-selective antigens
Nimbus Therapeutics partners with Lilly to develop oral obesity treatment
BioArctic and Eisai secure Chinese acceptance for subcutaneous Leqembi filing
Oculis secures FDA Breakthrough Therapy Designation for Privosegtor in optic neuritis
Nanjing Delova Biotech reports positive Phase 3 trial results for QP-6211 for postoperative pain
MetaVia reports positive results from Phase 1 clinical trial in obesity
RedHill advances RHB-102 across GI indications
Halozyme licenses ENHANZE to Skye Bioscience for nimacimab obesity programme
Kelun-Biotech lung cancer drug granted Breakthrough Therapy Designation in China
FDA grants priority review for Sanofi's Tzield in young children with stage 2 type 1 diabetes
GSK secures China approval for Nucala in COPD
Insilico Medicine signs multi-year research and development collaboration with Servier
WuXi Biologics achieves ISO 20400 Sustainable Procurement certification
ChemPartner updates its visual identity and digital experience